Photodynamic therapy of early squamous cell carcinoma with tetra(m-hydroxyphenyl)chlorin: Optimal drug-light interval

British Journal of Cancer

Volumn 76, Issue 8, 1997, Pages 1021-1028

  Andrejevic Blant, S ^a   Hadjur, Ch ^b   Ballini, J P ^b   Wagnieres G ^b   Fontolliet, Ch ^c   Van Den Bergh, H ^b   Monnier, Ph ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b EPFL   (Switzerland)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Biodistribution; Drug light interval; Early squamous cell carcinoma (SCC); Photodynamic therapy (PDT); Photosensitizer (PS); Tetra(m hydroxyphenyl)chlorin

Indexed keywords

PHOTOSENSITIZING AGENT; TETRAKIS(3 HYDROXYPHENYL)CHLORIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEEK POUCH; CONTROLLED STUDY; DRUG DISTRIBUTION; EARLY CANCER; FLUORESCENCE MICROSCOPY; INTRACARDIAC DRUG ADMINISTRATION; LAMINA PROPRIA; LIGHT; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RADIATION DOSE; SKELETAL MUSCLE; SQUAMOUS CELL CARCINOMA; SYRIAN HAMSTER; TIME; TREATMENT PLANNING; VASCULAR DISEASE; VASCULAR ENDOTHELIUM;

EID: 0030757658     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.502     Document Type: Article

References (32)

1. Andrejevic S, Savary JF, Monnier P, Braichotte D, Wagniéres G and van den Berg H (1996a) Measurement by fluorescence microscopy of the time dependent mesotetrahydroxyphenyl chlorin distribution in healthy tissues and chemically-induced "early" squamous cell carcinoma of the Syrian Hamster cheek pouch. J Photochem Photobiol B: Biol 36: 143-151
2. Andrejevic S, Savary JF, Fontolliet C, Monnier P and van den Bergh H (1996b) 7,12-dimethylbenz[a]anthracene-induced 'early' squamous cell carcinoma in the Golden Syrian hamster: evaluation of an animal model and comparison with 'early' forms of human squamous cell carcinoma in the upper aerodigestive tract. Int J Exp Pathol 77: 7-14
3. Andrejevic-Blant S, Woodtli A, Wangières G, Fontolliet C, van den Berg H and Monnier P (1996) In vivo fluence rate effects in Photodynamic Therapy performed at two wavelengths in an "early" squamous cell carcinoma model with tetra(m-hydroxyphenyl)chlorin. Photochem Photobiol 64: 963-968
4. Andrejevic-Blant S, Theumann J.-F, Forrer M, Wagnières G, van den Berg H and Monnier P (1997) Wavelength-dependent effect of tetra(m-hydroxyphenyl)chlorin for photodynamic therapy in an "early" squamous cell carcinoma model. Las Med Sci 12:
5. Barr H, Tralau CJ, Macrobert AJ, Morrison I, Philips D and Bown SG (1988) Fluorescence photometric techniques for determination of microscopic tissue distribution in phthalocyanine photosensitizers for photodynamic therapy. Las Med Sci 3: 81-86
6. Bedwell J, Macrobert AJ, Phillips D and Bown SG (1992) Fluorescence distribution and photodynamic effect of ALA-induced PP IX in the DMH rat colonic tumour model. Br J Cancer 65: 818-824
7. Berenbaum MC, Akande SL, Bonnett R, Kaur H, Ioannou S, White RD and Winfield UJ (1986) meso-Tetra(hydroxyphenyl)porphyrins, a new class of potent tumour photosensitisers with favourable selectivity. Br J Cancer 54: 717-725
8. Berenbaum M, Bonnett R, Chevretton E, Akande S, Ladebakin S and Ruston M (1993) Selectivity of meso-tetra(hydoxyphenyl)-porphyrins and chlorins and Photofrin II in causing photodamage in tumour, skin, muscle and bladder. The concept of cost-benefit in analysing the results. Las Med Sci 8: 235-242
9. Biel MA (1995) Photodynamic therapy of head and neck cancers. Semi Surg Oncol 11: 355-359
10. Braichotte D, Savary JF, Glanzmann T, Westermann P, Folli S, Wagnieres G, Monnier P and van den Bergh H (1995) Clinical pharmacokinetic studies of tetra(meta-hydroxyphenyl)chlorin in squamous cell carcinoma by fluorescence spectroscopy at 2 wavelengths. Int J Cancer 63: 198-204
11. Chapman MJ (1986) Comparative analysis of mammalian plasma lipoproteins. (review). Meth Enzymol 128: 70-143
12. Edell ES and Cortese DA (1992) Photodynamic therapy in the management of early superficial squamous cell carcinoma as an alternative to surgical resection (see comments). Chest 102: 1319-1322
13. Forrer M, Andrejevic-Blant S, Glanzmann T, Wagnières G, Monnier P and van den Bergh H (1997) Fluorescence uptake and photodynamic effect of Temoporfin in an early squamous cell carcinoma model. Photochem Photobiol (submitted)
14. Furuse K, Fukuoka M, Kato H, Horai T, Kubota K, Kodama N, Kusunoki Y, Takifuji N, Okunaka T, Konaka C, Wada C and Hayata Y (1993) A prospective phase II study on photodynamic therapy with phototrin II for centrally located early-stage lung cancer. The Japan Lung Cancer Photodynamic Therapy Study Group (see comments). J Clin Oncol 11: 1852-1857
15. Grant WE, Hopper C, Speight PM, Macrobert AJ and Bown SG (1993) Photodynamic therapy of malignant and premalignant lesions in patients with 'field cancerization' of the oral cavity. J Laryngol Otol 107: 1140-1145
16. Grosjean P, Savary J, Wagnières G, Mizeret J, Woodtli A, Theumann J, Fontolliet C, van den Berg H and Monnier P (1996) Tetra(m-hydroxyphenyl)chlorin clinical photodynamic therapy of early bronchial and esophageal cancer. Las Med Sci 11: 227-235
17. Hayata Y, Kato H and Konaka C (1993) Photodynamic therapy (PDT) in early stage lung cancer. Lung Cancer 9: 287-294
18. Henderson B and Dougherty T (1992a) Photodynamic Therapy: Basic Principles and Clinical Applications. Marcel Dekker: New York
19. Hua Z, Gibson SL, Foster TH and Hilf R (1995) Effectiveness of delta-aminolevulinic acid-induced protoporphyrin as a photosensitizer for photodynamic therapy in vivo. Cancer Res 55: 1723-1731
20. Iinuma S, Bachor R, Flotte T and Hasan T (1995) Biodistribution and phototoxicity of 5-aminolevulinic acid-induced PpIX in an orthotopic rat bladder tumor model. J Urol 153: 802-806.
21. Kessel D (1990) Photodynamic Therapy of Neoplastic Disease, vol. II. CRC Press: Boca Raton, FL, USA.
22. Kessel D and Woodburn K (1993) Biodistribution of photosensitizing agents. [Review]. Int J Biochem 25: 1377-1383
23. Lofgren LA, Ronn AM, Abramson AL, Shikowitz MJ, Nouri M, Lee CJ, Batti J and Steinberg BM (1994) Photodynamic therapy using m-tetra(hydroxyphenyl)-chlorin. An animal model. Arch Otolaryngol Head and Neck Surg 120: 1355-1362
24. Margaron P, Madarnas P, Quellet R and van Lier JE (1996) Biological activities of phthalocyanines. XVII histopathologic evidence for different mechanisms of EMT-6 tumor necrosis induced by photodynamic therapy with disulfonated aluminium phthalocyanine or photofrin. Anticancer Res 16: 613-620
25. Monnier P, Savary M, Fontolliet C, Wagnières G, Châtelain A, Cornaz P, Depeursinge C and van den Berg H (1990) Photodetection and photodynamic therapy of "early" squamous cell carcinomas of the pharynx, oesophagus and tracheo-bronchial tree. Las Med Sci 5: 149-169
26. Morlet L, Vonarx-Coinsmann V, Lenz P, Foultier MT, de Brito LX, Stewart C and Patrice T (1995) Correlation between meta(tetrahydroxyphenyl)chlorin (m-THPC) biodistribution and photodynamic effects in mice. J Photochem Photobiol B-Biol 28: 25-22
27. Peng Q, Moan J, Ma LW and Nesland JM (1995) Uptake, localization, and photodynamic effect of meso-tetra(hydroxyphenyl)porphine and its corresponding chlorin in normal and tumor tissues of mice bearing mammary carcinoma. Cancer Res 55: 2620-2626
28. Peng Q, Moan J, Ma L and Nesland J (1996) Correlation of subcellular and intratumoral photosensitizer localization with ultrastructural features after photodynamic therapy. Ultrastruct Pathol 20: 109-129
29. Ris HB, Altermatt HJ, Nachbur B, Stewart JC, Wang Q, Lim CK, Bonnett R and Althaus U (1993a) Effect of drug-light interval on photodynamic therapy with meta-tetrahydroxyphenylchlorin in malignant mesothelioma. Int J Cancer 53: 141-146
30. Ris HB, Altermatt HJ, Stewart CM, Schaffner T, Wang Q, Lim CK, Bonnett R and Althaus U (1993b) Photodynamic therapy with m-tetrahydroxyphenylchlorin in vivo: optimization of the therapeutic index. Int J Cancer 55: 245-249
31. Salley J (1954) Experimental carcinogenesis in cheek pouch of the Syrian hamster. J Den Res 33: 253-262
32. Whelpton R, Michael-Titus AT, Basra SS and Grahn M (1995) Distribution of temoporfin, a new photosensitizer for the photodynamic therapy of cancer, in a murine tumor model. Photochem Photobiol 61: 397-401